Good morning FITX investors. I hope all had a gre
Post# of 56323
Below is an excerpt from an article I read this morning. I am not posting the link to the article in particular, as it is actually concerning another stock, but, in the discussion in that article, I copied the following information. It concerns an issue some seem to be confused about which is if CEN is growing yet or not, pre-license.
The short answer is no, they are not. A list of the companies who we're allowed to grow, pre license if given. We are not on it.
From the content of the article and others it appears to me that H / C is taking painfully serious measures to insure there is not an oversupply of MMJ, and further, to allow the existing LP's to expand before granting many new license's. Also, it would appear, we have a few more people in front of us in the process to be a LP in that they we're granted the pre-license grow opportunity.
So, what does all of this mean? Well, to me, anyway, It means that we may have to do some more waiting, which I am OK with. It gives us time to have the BOD vetted, and move forward on the spin off, as well as get the AUDITED financials completed, and go forward on any M / A we may have planned. To me this is not a 'HURRY UP AND GET ER DONE' company plan, but a long term positioning in the global industry. It takes a minute, and besides, we we're not the first folks in the door. Many people have been involved in and with H / C way before we knocked on the door. So, this will take a minute. I just wanted to primarily clear up any mis-conceptions on our current situation in the process.
If you want the original post which the excerpt came from just pm me and I will supply it to you. But, out of respect to the 'terms of use', I have not posted it here.
Everyone, please do your own DD, don't be confused when you do not have to be. It is your money. GLTA
In order to ensure there is enough supply of medical marijuana in the market, Health Canada has allowed eight other companies to grow crops ahead of being licensed to sell. The regulator also made that list of companies public this week. It includes: ABcann Medicinals Inc., CannMedica Pharma Inc., Maricann Inc., Prairie Plant Systems Inc., RedeCan Pharm, Thunderbird Biomedical Inc., Tweed Farms Inc., and 167151 Canada Inc./Marihuana Médicale. Some of these companies, such as Tweed, have full licences at a main facility, but have been granted the partial licence for a second operation.